15.5 Million Adults Had Current ADHD Diagnosis in 2023
TUESDAY, Oct. 15, 2024 -- An estimated 15.5 million U.S adults had a current diagnosis of attention-deficit/hyperactivity disorder (ADHD) in 2023, according to research published in the Oct. 10 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Brooke S. Staley, Ph.D., from the CDC in Atlanta, and colleagues estimated the prevalence of ADHD diagnosis and treatment among U.S. adults using data from the National Center for Health Statistics Rapid Surveys System collected during October to November 2023.
The researchers found that based on self-report, an estimated 15.5 million U.S. adults (6.0 percent) had a current diagnosis of ADHD in 2023; about half received the diagnosis at age 18 years or older. In the previous year, 36.5 percent of adults with ADHD were not receiving any treatment, while one-third were receiving both medication and counseling or behavioral treatment. Of the approximately one-third of adults with ADHD who took a stimulant medication to treat their ADHD, 71.5 percent had difficulty filling their prescription because it was unavailable. About half of adults with ADHD have ever used telehealth for ADHD-related services.
"Results highlight the magnitude of ADHD as a public health issue across the life course," the authors write. "Although the majority of adults with current ADHD received counseling or medication treatment for their ADHD in the previous year, approximately one-third did not receive any type of treatment."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Lung Cancer Screening Beneficial to Age 80 for Candidates Fit for Surgery
FRIDAY, Sept. 12, 2025 -- People aged 75 to 80 years at last screen who are diagnosed with screen-detected lung cancer (LC) have lower overall survival, but those undergoing...
Sex Differences Seen in Characteristics, Course of Schizophrenia, Bipolar Disorder
FRIDAY, Sept. 12, 2025 -- Significant sex differences are seen in the characteristics and course of schizophrenia (SZ) and bipolar disorder (BD), according to a study published...
Potentially Inappropriate Medications Linked to Frailty at Cancer Diagnosis
FRIDAY, Sept. 12, 2025 -- For patients with newly diagnosed cancer, an increasing number of potentially inappropriate medications (PIMs), as identified by the Geriatric Oncology...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.